Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).PURPOSETo compare the clinical character...
Saved in:
Published in | Yonsei medical journal Vol. 61; no. 11; pp. 951 - 957 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Yonsei University College of Medicine
01.11.2020
연세대학교의과대학 |
Subjects | |
Online Access | Get full text |
ISSN | 0513-5796 1976-2437 1976-2437 |
DOI | 10.3349/ymj.2020.61.11.951 |
Cover
Loading…
Abstract | To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).PURPOSETo compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.MATERIALS AND METHODSSLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.RESULTSOf all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years.CONCLUSIONPatients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years. |
---|---|
AbstractList | To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).PURPOSETo compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.MATERIALS AND METHODSSLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.RESULTSOf all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years.CONCLUSIONPatients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years. Purpose: To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) atthe onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset(early-onset LN). Materials and Methods: SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renaloutcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk ofworse renal outcomes according to the onset time of LN. Results: Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups,respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function(34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1(2180.0–6788.3) mg/g vs. 2410.0 (1265.0–5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) andprogression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) inthe initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazardratio (HR) 3.56, 95% confidence interval (CI) 1.51–8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI1.03–20.17, p=0.045), compared with the early-onset LN group. Conclusion: Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes thanthose who develop LN within 5 years. KCI Citation Count: 0 |
Author | Lee, Sang-Won Park, Jung Hwan Kwon, Oh Chan Song, Jason Jungsik Park, Yong-Beom Park, Min-Chan |
AuthorAffiliation | Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Oh Chan orcidid: 0000-0001-7962-3697 surname: Kwon fullname: Kwon, Oh Chan organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 2 givenname: Jung Hwan orcidid: 0000-0003-2911-2711 surname: Park fullname: Park, Jung Hwan organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 3 givenname: Sang-Won orcidid: 0000-0002-8038-3341 surname: Lee fullname: Lee, Sang-Won organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 4 givenname: Jason Jungsik orcidid: 0000-0003-0662-7704 surname: Song fullname: Song, Jason Jungsik organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 5 givenname: Yong-Beom orcidid: 0000-0003-4695-8620 surname: Park fullname: Park, Yong-Beom organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 6 givenname: Min-Chan orcidid: 0000-0003-1189-7637 surname: Park fullname: Park, Min-Chan organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002638083$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kU9r3DAQxUVJSTZpvkBPPrYHuxr9saxLIYS0XViaEBJ6FLI9zirxSlvJDuy3rzYbCi2lp4HR7z3NzDslRz54JOQ90IpzoT_tNo8Vo4xWNVQAlZbwhixAq7pkgqsjsqASeCmVrk_IaUqPlDIFlB2TE86BKsabBVn_CDFhcYvejsVNxIR-spMLvrC-z43w4ENyqXC-WHo3OTuW1z7hVKzm7ZyK77hdx9xOxbS2vriycdz9G3hH3g52THj-Ws_I_Zeru8tv5er66_LyYlV2AvhUIjBp-56yTjPLW636pml6C2pQig0IYHGQLYheQCs4Co20HhRvaFOjGFrgZ-TjwdfHwTx1zgTrXupDME_RXNzeLY2WmoHQmf18YLdzu8G-y7tHO5ptdBsbdy_KP1-8W2efZ6Okzhek2eDDq0EMP2dMk9m41OE4Wo9hToYJKWopZV1nlB3QLoaUIg6_vwFq9nGaHKfZx2lqMAB5yP0yzV-izh3iyeO48X_SX_5jqHE |
CitedBy_id | crossref_primary_10_1093_rheumatology_keae236 crossref_primary_10_1177_09612033211030008 crossref_primary_10_1177_09612033231220726 crossref_primary_10_1016_j_ejr_2024_12_005 crossref_primary_10_1016_j_ekir_2024_10_021 crossref_primary_10_14412_1996_7012_2022_6_12_19 crossref_primary_10_7759_cureus_66270 crossref_primary_10_31450_ukrjnd_2_78__2023_08 |
Cites_doi | 10.1002/art.1780400928 10.1002/art.10461 10.1016/S0140-6736(14)60128-8 10.1038/nrneph.2017.85 10.1093/rheumatology/ker101 10.1038/ki.2010.13 10.1053/j.ajkd.2014.01.416 10.2215/CJN.00490109 10.1007/s10157-015-1179-y 10.1097/01.ASN.0000108969.21691.5D 10.1056/NEJM200010193431604 10.1056/NEJM198603063141004 10.1136/annrheumdis-2012-201940 10.1097/MD.0000000000002891 10.1136/ard.62.6.556 10.1136/annrheumdis-2014-206897 10.3109/s10165-009-0154-4 10.1191/0961203305lu2057oa 10.1007/s12016-010-8249-4 10.1177/0961203319860200 10.1136/ard.2008.088740 |
ContentType | Journal Article |
Copyright | Copyright: Yonsei University College of Medicine 2020. Copyright: Yonsei University College of Medicine 2020 2020 Yonsei University College of Medicine |
Copyright_xml | – notice: Copyright: Yonsei University College of Medicine 2020. – notice: Copyright: Yonsei University College of Medicine 2020 2020 Yonsei University College of Medicine |
DBID | AAYXX CITATION 7X8 5PM ACYCR |
DOI | 10.3349/ymj.2020.61.11.951 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1976-2437 |
EndPage | 957 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9592149 PMC7593100 10_3349_ymj_2020_61_11_951 |
GrantInformation_xml | – fundername: ; grantid: 6-2019-0111 |
GroupedDBID | --- .55 .GJ 123 29R 2WC 36B 5-W 53G 5RE 8JR 8XY 9ZL AAYXX ACYCR ADBBV ADRAZ AEGXH AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION CS3 DIK DU5 E3Z EBD EF. EMB EMOBN F5P GROUPED_DOAJ GX1 HYE KQ8 L7B M48 MK0 O5R O5S OK1 OVT P2P PGMZT RNS RPM SV3 TR2 X7M XSB ZGI ZXP 7X8 5PM |
ID | FETCH-LOGICAL-c413t-e125add02c92a3b97d888da17f772fe11aef5b14d41b43e49e06f738086e4fb13 |
IEDL.DBID | M48 |
ISSN | 0513-5796 1976-2437 |
IngestDate | Sun Mar 09 07:50:41 EDT 2025 Thu Aug 21 18:45:30 EDT 2025 Fri Jul 11 00:35:33 EDT 2025 Tue Jul 01 04:03:20 EDT 2025 Thu Apr 24 22:56:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c413t-e125add02c92a3b97d888da17f772fe11aef5b14d41b43e49e06f738086e4fb13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 https://www.eymj.org/DOIx.php?id=10.3349/ymj.2020.61.11.951 |
ORCID | 0000-0003-0662-7704 0000-0002-8038-3341 0000-0003-1189-7637 0000-0001-7962-3697 0000-0003-4695-8620 0000-0003-2911-2711 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3349/ymj.2020.61.11.951 |
PMID | 33107238 |
PQID | 2454655566 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9592149 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7593100 proquest_miscellaneous_2454655566 crossref_primary_10_3349_ymj_2020_61_11_951 crossref_citationtrail_10_3349_ymj_2020_61_11_951 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-11-01 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Yonsei medical journal |
PublicationYear | 2020 |
Publisher | Yonsei University College of Medicine 연세대학교의과대학 |
Publisher_xml | – name: Yonsei University College of Medicine – name: 연세대학교의과대학 |
References | Mok (10.3349/ymj.2020.61.11.951_ref8) 2005; 14 Gladman (10.3349/ymj.2020.61.11.951_ref12) 2002; 29 Takahashi (10.3349/ymj.2020.61.11.951_ref10) 2009; 19 Inker (10.3349/ymj.2020.61.11.951_ref20) 2014; 63 Houssiau (10.3349/ymj.2020.61.11.951_ref16) 2002; 46 Bertsias (10.3349/ymj.2020.61.11.951_ref18) 2012; 71 Yu (10.3349/ymj.2020.61.11.951_ref3) 2017; 13 Weening (10.3349/ymj.2020.61.11.951_ref13) 2004; 15 Tamirou (10.3349/ymj.2020.61.11.951_ref22) 2016; 75 Austin (10.3349/ymj.2020.61.11.951_ref17) 1986; 314 Galindo-Izquierdo (10.3349/ymj.2020.61.11.951_ref5) 2016; 95 Hochberg (10.3349/ymj.2020.61.11.951_ref11) 1997; 40 Yu (10.3349/ymj.2020.61.11.951_ref14) 2010; 77 Lisnevskaia (10.3349/ymj.2020.61.11.951_ref1) 2014; 384 Nakano (10.3349/ymj.2020.61.11.951_ref21) 2019; 28 Alba (10.3349/ymj.2020.61.11.951_ref2) 2003; 62 Chan (10.3349/ymj.2020.61.11.951_ref15) 2000; 343 Gibson (10.3349/ymj.2020.61.11.951_ref19) 2009; 4 Varela (10.3349/ymj.2020.61.11.951_ref9) 2008; 67 Croca (10.3349/ymj.2020.61.11.951_ref4) 2011; 50 Anaya (10.3349/ymj.2020.61.11.951_ref7) 2011; 40 Imran (10.3349/ymj.2020.61.11.951_ref6) 2016; 20 |
References_xml | – volume: 40 start-page: 1725 year: 1997 ident: 10.3349/ymj.2020.61.11.951_ref11 publication-title: Arthritis Rheum doi: 10.1002/art.1780400928 – volume: 46 start-page: 2121 year: 2002 ident: 10.3349/ymj.2020.61.11.951_ref16 publication-title: Arthritis Rheum doi: 10.1002/art.10461 – volume: 384 start-page: 1878 year: 2014 ident: 10.3349/ymj.2020.61.11.951_ref1 publication-title: Lancet doi: 10.1016/S0140-6736(14)60128-8 – volume: 13 start-page: 483 year: 2017 ident: 10.3349/ymj.2020.61.11.951_ref3 publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2017.85 – volume: 50 start-page: 1424 year: 2011 ident: 10.3349/ymj.2020.61.11.951_ref4 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ker101 – volume: 77 start-page: 820 year: 2010 ident: 10.3349/ymj.2020.61.11.951_ref14 publication-title: Kidney Int doi: 10.1038/ki.2010.13 – volume: 29 start-page: 288 year: 2002 ident: 10.3349/ymj.2020.61.11.951_ref12 publication-title: J Rheumatol – volume: 63 start-page: 713 year: 2014 ident: 10.3349/ymj.2020.61.11.951_ref20 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2014.01.416 – volume: 4 start-page: 1962 year: 2009 ident: 10.3349/ymj.2020.61.11.951_ref19 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.00490109 – volume: 20 start-page: 1 year: 2016 ident: 10.3349/ymj.2020.61.11.951_ref6 publication-title: Clin Exp Nephrol doi: 10.1007/s10157-015-1179-y – volume: 15 start-page: 241 year: 2004 ident: 10.3349/ymj.2020.61.11.951_ref13 publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000108969.21691.5D – volume: 343 start-page: 1156 year: 2000 ident: 10.3349/ymj.2020.61.11.951_ref15 publication-title: N Engl J Med doi: 10.1056/NEJM200010193431604 – volume: 314 start-page: 614 year: 1986 ident: 10.3349/ymj.2020.61.11.951_ref17 publication-title: N Engl J Med doi: 10.1056/NEJM198603063141004 – volume: 71 start-page: 1771 year: 2012 ident: 10.3349/ymj.2020.61.11.951_ref18 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-201940 – volume: 95 start-page: e2891 year: 2016 ident: 10.3349/ymj.2020.61.11.951_ref5 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000002891 – volume: 62 start-page: 556 year: 2003 ident: 10.3349/ymj.2020.61.11.951_ref2 publication-title: Ann Rheum Dis doi: 10.1136/ard.62.6.556 – volume: 75 start-page: 526 year: 2016 ident: 10.3349/ymj.2020.61.11.951_ref22 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2014-206897 – volume: 19 start-page: 293 year: 2009 ident: 10.3349/ymj.2020.61.11.951_ref10 publication-title: Mod Rheumatol doi: 10.3109/s10165-009-0154-4 – volume: 14 start-page: 39 year: 2005 ident: 10.3349/ymj.2020.61.11.951_ref8 publication-title: Lupus doi: 10.1191/0961203305lu2057oa – volume: 40 start-page: 199 year: 2011 ident: 10.3349/ymj.2020.61.11.951_ref7 publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-010-8249-4 – volume: 28 start-page: 1062 year: 2019 ident: 10.3349/ymj.2020.61.11.951_ref21 publication-title: Lupus doi: 10.1177/0961203319860200 – volume: 67 start-page: 1044 year: 2008 ident: 10.3349/ymj.2020.61.11.951_ref9 publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.088740 |
SSID | ssj0027102 |
Score | 2.2853038 |
Snippet | To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus... Purpose: To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) atthe onset of systemic lupus... |
SourceID | nrf pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 951 |
SubjectTerms | Original 의학일반 |
Title | Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis |
URI | https://www.proquest.com/docview/2454655566 https://pubmed.ncbi.nlm.nih.gov/PMC7593100 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002638083 |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Yonsei Medical Journal, 2020, 61(11), , pp.951-957 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELa2ISFeED9FGVQG8YZc6sRO4geEEGLaEB0IUW1vVpyct7LibEkrsf-euyTdiDQQT5GSixPd2b777PN3jL3SEcSJ00qoCLRQGkC4VJYtbWWsvELsQ-sds8Nkf64-HevjLbYpd9QrsLkR2lE9qXm9nPy6uHyHA_4tIc5YmTeXP38g0Iumk0TiDDAxdKL6FnqmhHr5TGXXAEx2OYjoggUR8XWHaP7SxsBRbYfaD2LQYQblHy5p7x6728eS_H1n_PtsC8IDdnvW75Y_ZKdHVd0A_wYk9fX6nFHgeSjxRkVJdouGLwI_oByifCm-hAZW_PP6fN3wQ0BDE-URp-V13lIh3yzwiM33Pn7_sC_6ygqiQKe1EoBhDU5s06gwUR47k5YIhMtcph6DbQ9S5uC1k6pU0qkYlIFp4tM4Q_wDyjsZP2Y7oQrwhHGfGZ-6OFMm06osUoczKEKakighp2VWjJjcqNEWPe04Vb9YWoQfpHqLqrekeptIxCMWVT9ir6_eOe9IN_4p_RKtY8-KhSWubLqeVPastogIDlDARIgCR-zFxngWBxDtiuQBqnVjI0X14DWGtSOWDqx69W1qdvgkLE5bKu5UG9ohefofre-yO_Tf3TnGZ2xnVa_hOQY0Kzdm21ocjdvlgHHbY38DttL09g |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Worse+Renal+Presentation+and+Prognosis+in+Initial-Onset+Lupus+Nephritis+than+Early-Onset+Lupus+Nephritis&rft.jtitle=Yonsei+medical+journal&rft.au=Kwon%2C+Oh+Chan&rft.au=Park%2C+Jung+Hwan&rft.au=Lee%2C+Sang+Won&rft.au=Song%2C+Jason+Jungsik&rft.date=2020-11-01&rft.issn=1976-2437&rft.eissn=1976-2437&rft.volume=61&rft.issue=11&rft.spage=951&rft_id=info:doi/10.3349%2Fymj.2020.61.11.951&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon |